|
US6828415B2
(en)
*
|
1993-02-19 |
2004-12-07 |
Zentaris Gmbh |
Oligopeptide lyophilisate, their preparation and use
|
|
WO2000025820A1
(en)
*
|
1998-11-04 |
2000-05-11 |
Pharmadigm, Inc. |
Compounds and methods for genetic immunization
|
|
US6656471B1
(en)
|
1998-11-17 |
2003-12-02 |
Board Of Regents, The University Of Texas System |
HIV-specific T-cell induction
|
|
AU2579600A
(en)
*
|
1999-01-28 |
2000-08-18 |
Stichting Biomedical Primate Research Centre |
Product and method for obtaining specific immunisation with one or more antigens
|
|
US6870043B2
(en)
|
2000-04-06 |
2005-03-22 |
The University Of Iowa Research Foundation |
Full-length GB virus C (hepatitis G virus) RNA transcripts are infectious in primary CD4 positive T cells
|
|
US7569218B2
(en)
*
|
2000-07-27 |
2009-08-04 |
The Trustees Of The University Of Pennsylvania |
Compositions for and methods of using herpes simplex virus glycoprotein D to suppress immune responses
|
|
KR100369237B1
(ko)
*
|
2000-09-14 |
2003-01-24 |
김원중 |
음식물 쓰레기와 축산폐수의 혼합처리 방법
|
|
GB0023008D0
(en)
*
|
2000-09-20 |
2000-11-01 |
Glaxo Group Ltd |
Improvements in vaccination
|
|
US6867000B2
(en)
*
|
2000-12-07 |
2005-03-15 |
Wyeth Holdings Corporation |
Method of enhancing immune responses to herpes
|
|
CA2484044A1
(en)
*
|
2002-03-19 |
2003-10-02 |
Powdermed Limited |
Imidazoquinolineamines as adjuvants in hiv dna vaccination
|
|
DK1523582T3
(da)
|
2002-07-18 |
2009-03-02 |
Univ Washington |
Hurtig, effektiv rensning af HSV-specifikke T-lymfocytter samt HSV-antigener identificeret derved
|
|
AU2003287216A1
(en)
*
|
2002-10-24 |
2004-05-13 |
Sarah George |
Gb virus c and methods of treating viral infections
|
|
AU2007281934B2
(en)
|
2006-01-18 |
2012-11-15 |
University Of Chicago |
Compositions and methods related to Staphylococcal bacterium proteins
|
|
EP2341929B1
(en)
|
2008-10-06 |
2017-01-25 |
University Of Chicago |
Compositions and methods related to bacterial emp proteins
|
|
US9044447B2
(en)
|
2009-04-03 |
2015-06-02 |
University Of Washington |
Antigenic peptide of HSV-2 and methods for using same
|
|
HUE026855T2
(en)
|
2009-04-03 |
2016-07-28 |
Univ Chicago |
Compositions and methods related to protein a (spa) variants
|
|
EP3756684A1
(en)
|
2009-05-22 |
2020-12-30 |
Genocea Biosciences, Inc. |
Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
|
|
EP2555794A4
(en)
|
2010-04-05 |
2014-01-15 |
Univ Chicago |
COMPOSITIONS AND METHODS RELATING TO PROTEIN A (SPA) ANTIBODIES AS IMMUNE REACTION AMPLIFIERS
|
|
CA2803298C
(en)
|
2010-07-02 |
2020-07-14 |
The University Of Chicago |
Compositions and methods related to protein a (spa) variants
|
|
EP2614074A1
(en)
|
2010-09-09 |
2013-07-17 |
The University of Chicago |
Methods and compositions involving protective staphylococcal antigens
|
|
JP6055776B2
(ja)
|
2010-11-24 |
2016-12-27 |
ジェノセア バイオサイエンシーズ， インコーポレイテッド |
単純ヘルペスウイルス２型に対するワクチン：免疫応答を誘発する組成物及び方法
|
|
US8945588B2
(en)
|
2011-05-06 |
2015-02-03 |
The University Of Chicago |
Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
|
|
AU2012340712B2
(en)
|
2011-11-23 |
2017-09-14 |
Genocea Biosciences, Inc. |
Nucleic acid vaccines against Herpes Simplex Virus type 2: compositions and methods for eliciting an immune response
|
|
JP6670106B2
(ja)
|
2012-04-26 |
2020-03-18 |
ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ |
ブドウ球菌コアグラーゼ抗原およびその使用方法
|
|
US10350288B2
(en)
|
2016-09-28 |
2019-07-16 |
Genocea Biosciences, Inc. |
Methods and compositions for treating herpes
|
|
WO2019183500A1
(en)
|
2018-03-23 |
2019-09-26 |
Hung Chiung Yu |
Coccidioides antigens and methods of their use
|
|
US12514914B2
(en)
|
2019-05-14 |
2026-01-06 |
The University Of Chicago |
Methods and compositions comprising Staphylococcus protein a (SpA) variants
|